Impact of Yogotherapeutics on Chronic Pains' Patients (YOGADO)
Impact of Yogotherapeutics in Consultation on Chronic Pains' Patients
調査の概要
詳細な説明
Yoga is a discipline that has its origins in India for nearly 5,000 years, and which aims to bring physical, mental and spiritual well-being through postures, stretching, breathing exercises and meditation.
Non-invasive and having very few side effects, this approach allows the practitioner to reclaim their body, to know themselves better, to accept their limits, to respect them and to empower themselves in their care and pathology.
More and more studies are now looking at the positive effect of yoga whether it is on stress by demonstrating the drop in cortisol in participants, or on the reduction of symptoms of depression, improvement of immune function, or pain.
To our knowledge, no study of the impact of yoga for analgesic treatment has been carried out in France.
Through this retrospective study, the investigators wish to demonstrate a reduction in pain and / or an improvement in the quality of life.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Pontoise、フランス、95300
- Departement of Chronic Pain Consultation, Hospital René Dubos,
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Patient ≥ 18 years old,
- Seen in consultation for chronic pain with implementation of Yogatherapy,
Exclusion Criteria:
- Patient < 18 years old,
- No indication for Yogatherapy treatment (Severe cognitive disorder / Major unbalanced psychological disorder),
- Trauma pathology and / or acute fracture in progress,
- Patient refusal to participate.
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Yogatherapy
Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
|
Description: Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Evolution of the patient's pain
時間枠：Between the 1st and the 5th consultation, an average of 3 to 5 month
|
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the 5th consultation, using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
|
Between the 1st and the 5th consultation, an average of 3 to 5 month
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Evolution of the patient's pain over time
時間枠：Between the 1st and the 5th consultation, an average of 3 to 5 month
|
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the last consultation (number 10 maximum), using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
|
Between the 1st and the 5th consultation, an average of 3 to 5 month
|
|
Improvement of patient's sleep
時間枠：Between the 1st and the last consultation, an average of 5 to 10 month
|
The impact of pain on sleep is evaluated by questioning the patient at the first and last consultation (number 10 maximum) The answer to the question is YES or NO
|
Between the 1st and the last consultation, an average of 5 to 10 month
|
|
Evolution of the patient's quality of life
時間枠：Between the 1st and the last consultation, an average of 5 to 10 month
|
The quality of life is assessed at all visits, by questioning patient, on the following elements: work, daily activities, mood…. to obtain a score on a numerical scale between 0 and 10 Results are interpreted as following : EN ≤ 5 = Very degraded, 6 ≥ EN ≤ 7 = Degraded and EN > 7 = Normal) |
Between the 1st and the last consultation, an average of 5 to 10 month
|
|
Evolution of the patient's therapeutic
時間枠：Between the 1st and the last consultation, an average of 5 to 10 month
|
The evolution of the therapeutic is evaluated by questioning the patient at the first and last consultation (number 10 maximum) about their treatment: treatment name, indication, dosage, number of doses per day, decrease or increase for each treatment ……. to see if there is a decrease or not in the patient's therapies.
|
Between the 1st and the last consultation, an average of 5 to 10 month
|
協力者と研究者
捜査官
- 主任研究者：Jocelyne BOREL-KUHNER、Hospital René Dubos,
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。